Location History:
- Saubens, FR (2012)
- Souilhanels, FR (2005 - 2015)
Company Filing History:
Years Active: 2005-2015
Title: Marie-Dominique Ibarra: Innovator in Pharmaceutical Chemistry
Introduction
Marie-Dominique Ibarra is a prominent inventor based in Souilhanels, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. With a total of 3 patents to her name, Ibarra's work has the potential to impact the medical industry positively.
Latest Patents
Ibarra's latest patents include groundbreaking inventions that focus on the stabilization and formulation of vinca alkaloids. One of her notable patents is for a stable solid dispersion of a derivative of vinca alkaloid and the process for manufacturing it. This invention relates to solid and stable dispersions of a hydrosoluble derivative of vinca alkaloids in at least one polyethyleneglycol with a molecular mass between 800 and 30,000. Another significant patent is for a freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrates that remain stable at room temperature. This invention consists of a semisynthetic derivative of vinca alkaloid, stable at room temperature, in which the derivative is present in the form of a freeze-dried product obtained in the presence of at least one carbohydrate.
Career Highlights
Marie-Dominique Ibarra is currently associated with Pierre Fabre Medicament, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to improving drug stability and efficacy, which is crucial for patient care.
Collaborations
Ibarra has collaborated with notable colleagues such as Elie Leverd and Joël Bougáret, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Marie-Dominique Ibarra's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also has the potential to improve therapeutic options for patients.